After the peak, parasitemia in isotype control and anti-CXCR3 treated groups decreased, and on day 13, the parasitemia levels increased again only in anti-CXCR3 treated group (Fig 2B). This evidence concerns the gene CXCR3 and parasitic infectious disease.